Germline BAP1 mutations are indeed associated with a cancer syndrome characterized by an increased risk of malignant mesothelioma, atypical melanocytic tumors (melanocytic BAP1-mutated atypical intradermal tumors), uveal and cutaneous melanoma, and other neoplasms [13]. The gene discussed is BAP1; the disease is cutaneous melanoma.